ALPRAZolam 0.25 mg Oral Tablet
RxNorm 308047
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 308047 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ALPRAZolam 0.25 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Alprazolam 0.25 mg Oral Tablet
(Atom ID: 12342231)
PSNPrescribable
Prescribable Name (PSN):
ALPRAZolam 0.25 mg Oral Tablet
(Atom ID: 6362730)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ALPRAZolam 0.25 mg Oral Tablet
(Atom ID: 3733909)
PTPrescribable
Designated preferred name (PT):
Alprazolam 250 microgram oral tablet
(Atom ID: 10293574)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely alprazolam 250 microgram/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10308991)
Patient Education
Alprazolam
Alprazolam is used to treat anxiety disorders and panic disorder (sudden, unexpected attacks of extreme fear and worry about these attacks). Alprazolam is in a class of medications called benzodiazepines. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.